These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3488941)

  • 21. [Thymic polypeptide factor--thymalin in experiments and in clinical use].
    Sofronov BN; Morozov VG; Khavinson VKh; Belokrylov GA
    Fiziol Cheloveka; 1984; 10(2):229-33. PubMed ID: 6335878
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinico-experimental basis for using thymalin in osteomyelitis and suppurative-inflammatory diseases of soft tissues in children].
    Solov'ev MM; Supiev TK; Alekhova TM; Khavinson VKh; Morozov VG
    Pediatriia; 1983 Sep; (9):26-9. PubMed ID: 6689207
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of thymalin on the status of immunogenesis and hemostasis in patients with ischemic heart disease].
    Kuznik BI; Budazhabon GB; Sytnikova IA; Morozov VG; Khavinson VKh
    Ter Arkh; 1986; 58(5):90-3. PubMed ID: 3488603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thymus and bone marrow origin of leukemic lymphoid cells in acute leukemia in children].
    Sokolov PP; Izotova TA
    Pediatriia; 1973 Dec; 52(12):45-8. PubMed ID: 4594943
    [No Abstract]   [Full Text] [Related]  

  • 25. T and B lymphocytes in leukemia therapy.
    Esber E; DiNicola W; Movassaghi N; Leikin S
    Am J Hematol; 1976; 1(2):211-8. PubMed ID: 1087115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [T and B lymphocytes before, during, and after cytostatic therapy of acute lymphoblastic leukemia (ALL) in children (author's transl)].
    Wehinger H; Karitzky D
    Klin Padiatr; 1977 May; 189(3):234-41. PubMed ID: 301585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of THF in lymphoproliferative and myeloproliferative diseases in children.
    Zaizov R; Vogel R; Wolach B; Cohen IJ; Varsano I; Shohat B; Handzel Z; Rotter V; Yakir Y; Trainin N
    Ann N Y Acad Sci; 1979; 332():172-83. PubMed ID: 294830
    [No Abstract]   [Full Text] [Related]  

  • 29. Thymic hormone (THF) therapy in immunosuppressed children with lymphoproliferative neoplasia and generalized varicella.
    Zaizov R; Vogel R; Cohen I; Varsano I; Shohat B; Rotter V; Trainin N
    Biomedicine; 1977 Apr; 27(3):105-8. PubMed ID: 268220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies of the immunological profile in acute lymphoblastic leukemia in children].
    Esposito L; Guerriero A; Benedetto N; Dell'Aquila P
    Pediatria (Napoli); 1979 Jun; 87(2):173-82. PubMed ID: 317666
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of thymalin on the immunological indices and morphofunctional structure of the uterus in guinea pigs with endometrial hyperplasia].
    Zaporozhan VN; Khait OV; Li LN
    Biull Eksp Biol Med; 1989 Feb; 107(2):251-3. PubMed ID: 2784333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying and enumerating human T and B lymphocytes. A review of techniques, problems, and progress in clinical studies.
    Dwyer JM
    Prog Allergy; 1976; 21():178-260. PubMed ID: 794886
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunological indicators in children with laryngeal papillomatosis and possible ways of immunocorrection].
    Garashchenko TI; Markova TP; Chuvirov DG
    Vestn Otorinolaringol; 1996; (4):15-8. PubMed ID: 8966870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thymalin correction of the immunologic deficiency state in children with congenital 1st and 2d branchial arch syndrome].
    Kotov GA; Iarchuk NI; Khavinson VKh; Morozov VG; Kozhemiakin AL
    Pediatriia; 1983 May; (5):54-5. PubMed ID: 6688298
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indicators of immunologic reactivity in patients with lymphoblastic leukemia during cytostatic therapy].
    Vygovskaia IaI; Korotkiĭ VV; Loginskiĭ VE; Mazurok AA
    Gematol Transfuziol; 1985 Jul; 30(7):21-5. PubMed ID: 3863773
    [No Abstract]   [Full Text] [Related]  

  • 36. [Subvariants of T-cell acute lymphoblastic leukemia in children].
    Adzhimamudova TS; Baĭdun LV; Kondratchik KL; Lenskaia RV; Rumiantsev AG
    Gematol Transfuziol; 1987 Aug; 32(8):33-7. PubMed ID: 3500092
    [No Abstract]   [Full Text] [Related]  

  • 37. [The number of active rosette-forming cells in the peripheral blood of children with O-cell variant of acute lymphoid leukemia].
    Baĭdun LV; Izotova TA
    Gematol Transfuziol; 1985 Mar; 30(3):17-20. PubMed ID: 3874113
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.
    Greaves MF; Janossy G; Peto J; Kay H
    Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inhibitor of thymic hormone activity in serum from patients with lymphoblastic leukemia.
    Twomey JJ; Lewis VM; Ford R; Goldstein G
    Am J Med; 1980 Mar; 68(3):377-80. PubMed ID: 6965820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human serum thymic factor increases E-rosettes in acute lymphocytic leukaemia.
    Pasino M; Tonini GP; Rosanda C; Massimo L
    Lancet; 1977 Mar; 1(8011):608. PubMed ID: 65699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.